An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration.

An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration.

Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elite control (EC) of HIV infection. Although numerous definitions of EC exist, it is not clear which, if any, best identify this rare phenotype.We assessed a number of EC definitions used in the literatu...

Full description

Bibliographic Details
Main Authors:	Ashley D Olson, Laurence Meyer, Maria Prins, Rodolphe Thiebaut, Deepti Gurdasani, Marguerite Guiguet, Marie-Laure Chaix, Pauli Amornkul, Abdel Babiker, Manjinder S Sandhu, Kholoud Porter, CASCADE Collaboration in EuroCoord
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3904947?pdf=render

Similar Items

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
by: Nikos Pantazis, et al.
Published: (2012-01-01)

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
by: Giota Touloumi, et al.
Published: (2013-01-01)

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014.
by: Ruth Simmons, et al.
Published: (2015-01-01)

HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014.
by: Ruth Simmons, et al.
Published: (2016-01-01)

The UK register of HIV seroconverters: methods and analytical issues. UK register of HIV seroconverters (UKRHS) Steering Committee.
by: Beral, V, et al.
Published: (1996)

Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters.
by: Babiker, A, et al.
Published: (2003)

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors
by: Dimitrios Paraskevis, et al.
Published: (2019-01-01)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
by: Gossez, M, et al.
Published: (2018)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.
by: Amornkul, P, et al.
Published: (2013)

The AIDS incubation period in the UK estimated from a national register of HIV seroconverters
by: Beral, V, et al.
Published: (1998)

The relationship between HIV seroconversion illness, HIV test interval and time to AIDS in a seroconverter cohort.
by: Tyrer, F, et al.
Published: (2003)

Complimentary Methods for Multivariate Genome-Wide Association Study Identify New Susceptibility Genes for Blood Cell Traits
by: Segun Fatumo, et al.
Published: (2019-04-01)

The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
by: Kristi Huik, et al.
Published: (2019-01-01)

4 Post-treatment control or treated controllers? The impact of ART on time to viral rebound in recent seroconverters
by: G.E. Martin, et al.
Published: (2016-07-01)

Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women.
by: Suchetha Murthy, et al.
Published: (2011-01-01)

Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.
by: Mary S Campbell, et al.
Published: (2011-03-01)

Protective effect of KIR3DS1 in asymptomatic HIV-1 seroconverters towards AIDS
by: Stalinraja M, et al.
Published: (2012-05-01)

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
by: Altmann Mathias, et al.
Published: (2012-04-01)

Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
by: Su-Ru Lin, et al.
Published: (2021-06-01)

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
by: Marcel Wolbers, et al.
Published: (2010-02-01)

Host genetic factors associated with symptomatic primary HIV infection and disease progression among Argentinean seroconverters.
by: Romina Soledad Coloccini, et al.
Published: (2014-01-01)

Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.
by: Lars Peters, et al.
Published: (2013-01-01)

Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort.
by: Charlotte H B S van den Berg, et al.
Published: (2011-01-01)

Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes
by: Robert Z. Harms, et al.
Published: (2018-10-01)

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.
by: CASCADE Collaboration
Published: (2003)

Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death.
by: Maria Casadellà, et al.
Published: (2017-01-01)

Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe.
by: Alexander Zoufaly, et al.
Published: (2014-01-01)

Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters.
by: Bhaskaran, K, et al.
Published: (2004)

Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
by: Karita, E, et al.
Published: (2007)

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana
by: Natasha O. Moraka, et al.
Published: (2023-10-01)

Complete blood counts with red blood cell determinants associate with reduced beta‐cell function in seroconverted Swedish TEDDY children
by: Falastin Salami, et al.
Published: (2021-07-01)

Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence.
by: Janet M McNicholl, et al.
Published: (2011-01-01)

Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire
by: Albert Minga, et al.
Published: (2007-02-01)

Long reads: Their purpose and place
by: Pollard, MO, et al.
Published: (2018)

Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort
by: Van Santen, D, et al.
Published: (2019)

Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report
by: Guang Zeng, et al.
Published: (2022-11-01)

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
by: Daniel Mrak, et al.
Published: (2022-09-01)

Schistosomiasis was not associated with higher HIV-1 plasma or genital set point viral loads among HIV seroconverters from four cohort studies.
by: Aaron F Bochner, et al.
Published: (2019-11-01)

Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore.
by: Oon Tek Ng, et al.
Published: (2011-01-01)

On the fallibility of simulation models in informing pandemic responses
by: Deepti Gurdasani, et al.
Published: (2020-06-01)